MicroRNA News and Research

RSS
In genetics, microRNAs (miRNA) are single-stranded RNA molecules of 21-23 nucleotides in length, which regulate gene expression. miRNAs are encoded by genes from whose DNA they are transcribed but miRNAs are not translated into protein (i.e. they are non-coding RNAs); instead each primary transcript (a pri-miRNA) is processed into a short stem-loop structure called a pre-miRNA and finally into a functional miRNA. Mature miRNA molecules are partially complementary to one or more messenger RNA (mRNA) molecules, and their main function is to down-regulate gene expression.
Press conference highlights emerging treatments in pancreatic cancer

Press conference highlights emerging treatments in pancreatic cancer

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Findings may lead to new drug therapies to reduce breast cancer metastasis

Findings may lead to new drug therapies to reduce breast cancer metastasis

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

InteRNA Technologies and Dana-Farber Cancer Institute team up for cancer research

InteRNA Technologies and Dana-Farber Cancer Institute team up for cancer research

IGR Genomic Center awarded ISO 9001 certification

IGR Genomic Center awarded ISO 9001 certification

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

GeneGo to launch new web site with high quality pathway content

GeneGo to launch new web site with high quality pathway content

Repros Therapeutics amends its existing license for Proellex

Repros Therapeutics amends its existing license for Proellex

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, GTG sign exclusive distribution agreement

NCI implements NanoString Technologies' nCounter Analysis System

NCI implements NanoString Technologies' nCounter Analysis System

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Certain molecules found to play an important role in regulating circadian rhythm: Study

Certain molecules found to play an important role in regulating circadian rhythm: Study

Applied Biosystems announces the commercial availability of SOLiD 3 Plus System

Applied Biosystems announces the commercial availability of SOLiD 3 Plus System

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.